CA971970A - Benzcyclobutene derivatives - Google Patents

Benzcyclobutene derivatives

Info

Publication number
CA971970A
CA971970A CA119,051A CA119051A CA971970A CA 971970 A CA971970 A CA 971970A CA 119051 A CA119051 A CA 119051A CA 971970 A CA971970 A CA 971970A
Authority
CA
Canada
Prior art keywords
benzcyclobutene
derivatives
benzcyclobutene derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA119,051A
Other languages
English (en)
Other versions
CA119051S (en
Inventor
Harm J. Panneman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzona Inc
Original Assignee
Akzona Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzona Inc filed Critical Akzona Inc
Application granted granted Critical
Publication of CA971970A publication Critical patent/CA971970A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/06—One of the condensed rings being a six-membered aromatic ring the other ring being four-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA119,051A 1970-08-07 1971-07-26 Benzcyclobutene derivatives Expired CA971970A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7011683A NL7011683A (fr) 1970-08-07 1970-08-07

Publications (1)

Publication Number Publication Date
CA971970A true CA971970A (en) 1975-07-29

Family

ID=19810731

Family Applications (1)

Application Number Title Priority Date Filing Date
CA119,051A Expired CA971970A (en) 1970-08-07 1971-07-26 Benzcyclobutene derivatives

Country Status (9)

Country Link
US (1) US3804898A (fr)
AU (1) AU3153171A (fr)
BE (1) BE771055A (fr)
CA (1) CA971970A (fr)
DE (1) DE2139526A1 (fr)
FR (1) FR2102106A1 (fr)
HU (1) HU162459B (fr)
NL (1) NL7011683A (fr)
ZA (1) ZA714729B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013682A (en) * 1973-08-03 1977-03-22 Akzona Incorporated N-hydroxy-amidine compounds
US4101675A (en) * 1973-11-09 1978-07-18 Akzona Incorporated Novel 2,6-di-substituted phenyl-aminoquanidine containing compositions and methods of using same and pharmaceutical compositions containing the same and therapeutic method
NL7315350A (nl) * 1973-11-09 1975-05-13 Akzo Nv Nieuwe aminoguanidine verbindingen.
NL7407469A (nl) * 1974-06-01 1975-12-03 Akzo Nv Nieuwe amidinohydrazonverbindingen.
US5478863A (en) * 1986-07-10 1995-12-26 State Of Oregon, Oregon Health Sciences University Of Oregon Substituted guanidines having high binding to the sigma receptor and the use thereof
US5312840A (en) * 1986-07-10 1994-05-17 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education Substituted guanidines having high binding to the sigma receptor and the use thereof
US5262568A (en) * 1990-03-02 1993-11-16 State Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
EP0517852B1 (fr) 1990-03-02 2002-07-10 STATE OF OREGON, acting by and through THE OREGON STATE BOARD OF HIGHER EDUCATION, acting for and on behalf of Guanidines tri et tetra substitues et leur utilisation en tant qu'antagonistes d'aminoacides excitateurs
US5336689A (en) * 1990-03-02 1994-08-09 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
JPH05508836A (ja) * 1990-05-25 1993-12-09 オレゴン州 シグマ受容体に対して高い結合性を有する置換グアニジンおよびその使用
AU670232B2 (en) * 1991-02-08 1996-07-11 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
US5741661A (en) * 1991-02-08 1998-04-21 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
US5847006A (en) * 1991-02-08 1998-12-08 Cambridge Neuroscience, Inc. Therapeutic guanidines
CA2163361C (fr) * 1993-05-27 2008-06-17 Graham J. Durant Derives de substitution de guanidines, agents therapeutiques
CA2177081A1 (fr) * 1993-11-23 1995-06-01 Graham J. Durant Guanidines substituees a usage therapeutique
US5914349A (en) 1994-01-10 1999-06-22 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
AU1867095A (en) * 1994-01-10 1995-08-01 Technion Research & Development Foundation Ltd. 1-aminoindan derivatives and compositions thereof
US7351743B1 (en) 1994-02-03 2008-04-01 Wyeth Therapeutic guanidines
US6143791A (en) * 1994-02-03 2000-11-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
ZA95878B (en) 1994-02-03 1996-01-16 Cambridge Neuroscience Inc Therapeutic guanidines
US6787569B1 (en) 1994-02-03 2004-09-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US6025355A (en) 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
US6242198B1 (en) 1996-07-25 2001-06-05 Cambridge Neuroscience, Inc. Methods of treatment of eye trauma and disorders
US6756389B2 (en) 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
JP4222632B2 (ja) 1996-12-18 2009-02-12 テバ・ファーマシューティカル・インダストリーズ・リミテッド アミノインダン誘導体
US6737547B1 (en) 1998-12-31 2004-05-18 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using N-acyl-1H-aminoindenes
US20040010038A1 (en) * 2002-02-27 2004-01-15 Eran Blaugrund Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors
WO2007070425A2 (fr) * 2005-12-09 2007-06-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem Utilisation de ladostigil a faible dose pour la neuroprotection
US20070135518A1 (en) * 2005-12-09 2007-06-14 Marta Weinstock-Rosin Use of low-dose ladostigil for neuroprotection
TW200744576A (en) * 2006-02-24 2007-12-16 Teva Pharma Propargylated aminoindans, processes for preparation, and uses thereof

Also Published As

Publication number Publication date
AU3153171A (en) 1973-01-25
FR2102106A1 (fr) 1972-04-07
HU162459B (fr) 1973-02-28
US3804898A (en) 1974-04-16
ZA714729B (en) 1972-04-26
BE771055A (nl) 1971-12-16
NL7011683A (fr) 1972-02-09
DE2139526A1 (fr) 1972-03-09

Similar Documents

Publication Publication Date Title
CA971970A (en) Benzcyclobutene derivatives
AU451793B2 (en) Pyridoquinoline derivatives
AU453008B2 (en) Triazolobenzodiazepine derivatives
AU466630B2 (en) Ergolene derivatives
CA1014574A (en) Phenylisopropylamine derivatives
AU448423B2 (en) Triazolobenzodiazepine derivatives
AU3306971A (en) Leucauramine derivatives
AU446117B2 (en) Dihydropyrimidopyridazine derivatives
AU2648271A (en) 2-amino-imidazol-2-ine derivatives
CA834197A (en) 6-phenylbenzazolyl derivatives
CA838131A (en) Benzepine derivatives
AU453581B2 (en) Indenopyridine derivatives
CA843968A (en) 2-alkylthiophen derivatives
AU462056B2 (en) Indenopyrrole derivatives
CA833558A (en) Sulfonyloxymorphinan derivatives
AU442249B2 (en) Terahydrocyclopropadibenzazepine derivatives
AU448291B2 (en) Bornanamine derivatives
AU448194B2 (en) Dibenzothiopene derivatives
AU448024B2 (en) Phenylaklane derivatives
CA835400A (en) Indenopyridine derivatives
AU444748B2 (en) Aryloxyalkylmorpholine derivatives
CA837137A (en) Penta-chlorobenzylidenamine derivatives
AU443255B2 (en) Evomonoside derivatives
CA837631A (en) Sulfonamidoindole derivatives
CA848475A (en) Pentafluorocinnamanilide derivatives